News
Harnessing Localized Surface Plasmon Resonance for Advanced Biosensing
At ArgusEye, our patented technology leverages nanoplasmonic sensing and fiber optics [...]
ArgusEye Makes It On ’33-Listan’ for the Third Time – Achieves ‘Gold Company’ Status
For the third consecutive year, ArgusEye has secured a spot [...]
The Purpose Behind the Auga™ Platform
At ArgusEye, we are dedicated to revolutionizing biopharmaceutical processing by offering [...]
The Countdown Begins: Just Two Months Until the Exciting Launch of AugaOne™!
With the product launch swiftly approaching, ArgusEye offers an exclusive sneak peek of the AugaOne™ system. ArgusEye is set to unveil its first official product at the 7th Bioprocessing Summit in Barcelona on March 21st. With only 2 months to [...]
ArgusEye – Among the Top 33 Tech Startups in Sweden, Once Again!
For the second consecutive year, ArgusEye proudly secures its place on the esteemed “33-listan” by the Swedish tech magazine Ny Teknik. This prestigious list recognizes Sweden’s most promising and innovative young tech companies. Since 2008, the Swedish tech magazine Ny Teknik, has annually highlighted the [...]
ArgusEye signs agreement with Optronic for intensified product development and increased manufacturing capacity
ArgusEye has recently entered into a strategic collaboration agreement with Optronic, an external partner specializing in product development and manufacturing. "We have been searching for a partner capable of manufacturing our hardware components while also providing support for our future product development. It feels [...]
ArgusEye – one of Sweden’s top Startups 2022
ArgusEye has been listed in the prestigious 33-listan by the Swedish tech magazine Ny Teknik, which acknowledges the most promising and innovative young tech companies in Sweden. Since 2008, the Swedish tech magazine Ny Teknik, has listed the 33 best young tech companies in [...]
ArgusEye closes deal with the downstream group within biological development at Bayer AG
The multinational pharmaceutical and biotechnology company, Bayer AG, has decided to purchase an in-line sensor system from ArgusEye AB (Linköping, Sweden) to accelerate their development of new therapies based on biopharmaceuticals. The sensor system, ArgusOne, developed and provided by ArgusEye enables faster and more [...]
Another successful week for ArgusEye during TESTA Challenge 2022
During March 14 – April 1, ArgusEye participated in the second edition of TESTA Challenge in Uppsala. This event is organized by TESTA Center in collaboration with STUNS, Cytiva, PALL Corporation and RISE with the objective to allow companies to validate new and innovative [...]